C33H40ClN5O7S — CID 118292665
[(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid (PubChem CID 118292665) has the molecular formula C33H40ClN5O7S and a molecular weight of 686.23 g/mol. Its IUPAC name is [(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid.
| Compound Name | [(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid |
|---|---|
| PubChem CID | 118292665 |
| Molecular Formula | C33H40ClN5O7S |
| Molecular Weight | 686.23 g/mol |
| Exact Mass | 685.23 |
| IUPAC Name | [(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid |
| SMILES | Cc1c(Cl)nc2ccccc2c1CN1C(=O)[C@@H](NC(=O)[C@H](CC(C)(C)C)N(C)C(=O)O)[C@H](C)N(C(=O)CS(C)(=O)=O)c2ccccc21 |
| InChI | InChI=1S/C33H40ClN5O7S/c1-19-22(21-12-8-9-13-23(21)35-29(19)34)17-38-24-14-10-11-15-25(24)39(27(40)18-47(7,45)46)20(2)28(31(38)42)36-30(41)26(16-33(3,4)5)37(6)32(43)44/h8-15,20,26,28H,16-18H2,1-7H3,(H,36,41)(H,43,44)/t20-,26-,28-/m0/s1 |
| InChIKey | IXBXXESMDJEVBX-GHKAFPQUSA-N |
| XLogP | 4.41 |
| TPSA | 157.29 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 47 |
| Complexity | — |
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 686.23 |
| LogP ≤ 5 | 4.41 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|